We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

pgd

Repevax and Infanrix-IPV PGDs extended until 31st October 2016

The current Patient Group Direction (PGD) for the pre-school booster (combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Repevax and Infanrix IPV vaccines) – NECSAT 2014/014) expires on 31st August 2016. The validity of this PGD has now been extended until 31st October 2016, unless replaced earlier.

read more about Repevax and Infanrix-IPV PGDs extended until 31st October 2016

Updated PGDs: Boostrix-IPV/ Repevax, Pneumococcal Vaccines, Hib/MenC Vaccine

The current Patient Group Directions for Boostrix-IPV, Pneumococcal (PPV and PCV) and Hib/MenC have been updated.

read more about Updated PGDs: Boostrix-IPV/ Repevax, Pneumococcal Vaccines, Hib/MenC Vaccine